Indel Therapeutics

About:

Indel Therapeutics is engaged in the development of new drugs to address the global health crisis caused by antibiotic resistance.

Website: http://www.indeltherapeutics.com/

Top Investors: Morningside Group, MAD Ventures, Quantum Pacific Capital

Description:

Indel Therapeutics Inc. is a Vancouver‐based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs focused on curing difficult‐to‐treat and hospital‐acquired infections. These programs are based on Indel's paradigm‐changing antimicrobial drug discovery platform, a patented technology that that has opened a rich, new area of antimicrobial drug targets for the treatment of infectious diseases and has the potential to provide an advantage against drug resistance.